Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
Male
Denmark
Coronary Disease
QD415-436
Apolipoproteins M
Biochemistry
03 medical and health sciences
FINRISK
Humans
signal peptide
Finland
Aged
Apolipoproteins B
0303 health sciences
Apolipoprotein A-I
Cholesterol, HDL
cholesterol
Copenhagen City Heart Study
Middle Aged
Lipocalins
3. Good health
Apolipoproteins
Logistic Models
Case-Control Studies
Female
lipocalin
DOI:
10.1194/jlr.m700471-jlr200
Publication Date:
2008-05-20T01:11:04Z
AUTHORS (9)
ABSTRACT
Apolipoprotein M (apoM), a 25 kDa plasma protein belonging to the lipocalin protein family, is predominantly associated with HDL. Studies in mice have suggested apoM to be important for the formation of pre-beta-HDL and to increase cholesterol efflux from macrophage foam cells. Overexpression of human apoM in LDL receptor-deficient mice reduced the atherogenic effect of a cholesterol-rich diet. The aim of the present study was to investigate whether the apoM levels in man predict the risk for coronary heart disease (CHD). ApoM was measured in samples from two separate case-control studies. FINRISK '92 consisted of 255 individuals, of whom 80 developed CHD during follow-up and 175 were controls. The Copenhagen City Heart Study included 1,865 individuals, of whom 921 developed CHD during follow-up and 944 were controls. Correlation studies of apoM concentration with several analytes showed a marked positive correlation with HDL and total cholesterol as well as with apoA-I and apoB. There was no significant difference in mean apoM level between CHD and control subjects in either study. In conditional logistic regression analyses, apoM was not a predictor of CHD events, [odds ratio (95% CI) 0.97 (0.74-1.27) and 0.92 (0.84-1.02), respectively]. In conclusion, no association between apoM and CHD could be found in this study.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....